Moderna (MRNA) Common Equity (2017 - 2026)
Moderna (MRNA) recorded Common Equity of $6.76 billion in Q2 2026, down 28.1% from $9.4 billion a year earlier and down 8.7% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna reported Common Equity of $8.65 billion, down 20.6% from FY2024.
- Annual Common Equity has declined for three straight years, though with a five-year compound annual growth rate of 27.6% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $10.9 billion in FY2024 (-21.3%), $13.85 billion in FY2023 (-27.6%), $19.12 billion in FY2022 (+35.2%) and $14.15 billion in FY2021 (+452.3%).
- The Q2 2026 figure is the lowest quarterly Common Equity since Q2 2021.
- On a year-over-year basis, Common Equity has declined for 13 consecutive quarters, with an average decline of 21.3% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 452.3% in Q4 2021, against a decline of 32.1% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $7.41 billion (Q1 2026), $8.65 billion (Q4 2025) and $9.33 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | 6.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.76 Bn |
| Mar 31, 2026 | 7.41 Bn |
| Dec 31, 2025 | 8.65 Bn |
| Sep 30, 2025 | 9.33 Bn |
| Jun 30, 2025 | 9.40 Bn |
| Mar 31, 2025 | 10.07 Bn |
| Dec 31, 2024 | 10.90 Bn |
| Sep 30, 2024 | 11.93 Bn |
| Jun 30, 2024 | 11.71 Bn |
| Mar 31, 2024 | 12.82 Bn |
| Dec 31, 2023 | 13.85 Bn |
| Sep 30, 2023 | 13.46 Bn |
| Jun 30, 2023 | 16.95 Bn |
| Mar 31, 2023 | 18.86 Bn |
| Dec 31, 2022 | 19.12 Bn |
| Sep 30, 2022 | 17.99 Bn |
| Jun 30, 2022 | 17.99 Bn |
| Mar 31, 2022 | 17.08 Bn |
| Dec 31, 2021 | 14.15 Bn |
| Sep 30, 2021 | 10.12 Bn |
API Access
Moderna Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();